Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001731122-24-001662
Filing Date
2024-10-28
Accepted
2024-10-28 16:08:45
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A3 e6063_s-1a3.htm S-1/A 550479
2 EXHIBIT 5.1 e6063_ex5-1.htm EX-5.1 9932
3 EXHIBIT 23.1 e6063_ex23-1.htm EX-23.1 3382
4 GRAPHIC image_005.jpg GRAPHIC 5619
5 GRAPHIC image_007.jpg GRAPHIC 7320
6 GRAPHIC image_001.jpg GRAPHIC 6908
7 GRAPHIC image_002.jpg GRAPHIC 134965
8 GRAPHIC image_003.jpg GRAPHIC 83684
9 GRAPHIC image_004.jpg GRAPHIC 3729
  Complete submission text file 0001731122-24-001662.txt   899292
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-281080 | Film No.: 241400955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)